Insulin and hypertensive cardiovascular disease
- 1 September 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Current Opinion in Cardiology
- Vol. 11 (5) , 483-489
- https://doi.org/10.1097/00001573-199609000-00006
Abstract
Resistance to insulin-stimulated glucose uptake is associated with several cardiovascular disease risk factors, including hypertension, dyslipidemia, and alterations of the blood clotting cascade that accentuate thrombosis. This constellation of risk factors may be recognized at young ages and is at least in part heritable. Recognition of this syndrome dictates that preventive and therapeutic strategies should address overall cardiovascular disease risk. In patients with hypertension or diabetes, additional clinical trials are required to identify those interventions that will most effectively reduce not only overall risk but also definitive cardiovascular disease endpoints.This publication has 8 references indexed in Scilit:
- Glycemic Control and the Risk for Coronary Heart Disease in Patients with Non-Insulin-dependent Diabetes Mellitus: The Finnish StudiesAnnals of Internal Medicine, 1996
- Do Non-Insulin-dependent Diabetes Mellitus and Cardiovascular Disease Share Common Antecedents?Annals of Internal Medicine, 1996
- Exogenous Insulin Administration and Cardiovascular Risk in Non-Insulin-dependent and Insulin-dependent Diabetes MellitusAnnals of Internal Medicine, 1996
- Effects of Antihypertensive Therapy on Serum LipidsAnnals of Internal Medicine, 1995
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA study.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes.Circulation, 1990
- Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertensionJAMA, 1988